OTC Drug Ads Rarely Mention Risks, Study Finds

Law360, New York (September 12, 2012, 8:48 PM EDT) -- Drug advertisements referenced a treatment's risks far less frequently when it was sold over-the-counter than when it was sold by prescription, according to a study published Wednesday, a disparity that could be attributable to the different regulations governing the types of drugs.

A drug's potential harms were mentioned in 70 percent of the print and broadcast prescription-drug advertisements examined in a Journal of the American Medical Association study, but in just 11 percent of over-the-counter drug advertisements.

The U.S. Food and Drug Administration regulates advertisements for...
To view the full article, register now.